Łukasz M Milanowski1, Jennifer A Lindemann2, Dorota Hoffman-Zacharska3, Alexandra I Soto-Beasley2, Maria Barcikowska4, Magdalena Boczarska-Jedynak5, Angela Deutschlander6, Gabriela Kłodowska7, Jarosław Dulski8, Lyuda Fedoryshyn9, Andrzej Friedman10, Zygmunt Jamrozik11, Piotr Janik11, Katherine Karpinsky12, Dariusz Koziorowski10, Anna Krygowska-Wajs13, Barbara Jasińska-Myga14, Grzegorz Opala14, Anna Potulska-Chromik11, Aleksander Pulyk15, Irena Rektorova16, Yanosh Sanotsky9, Joanna Siuda14, Jarosław Sławek8, Katarzyna Śmiłowska17, Lech Szczechowski17, Monika Rudzińska-Bar18, Ronald L Walton2, Owen A Ross2, Zbigniew K Wszolek19. 1. Department of Neurology, Mayo Clinic, Jacksonville, FL, USA; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA; Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland. 2. Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. 3. Department of Medical Genetics, Institute of Mother and Child, Warsaw, Poland. 4. Department of Neurodegenerative Disorders, Mossakowski Medical Research Centre, Polish Academy of Science, Warsaw, Poland. 5. Department of Neurology and Restorative Medicine, Health Institute Dr Boczarska-Jedynak, Oświęcim, Poland. 6. Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. 7. Neuro-Care Clinic, Siemianowice Śląskie, Poland. 8. Department of Neurology, St. Adalbert Hospital, Copernicus PL Ltd, Gdańsk, Poland; Department of Neurological and Psychiatric Nursing, Medical University of Gdańsk, Gdańsk, Poland. 9. Lviv Regional Clinical Hospital, Lviv, Ukraine. 10. Department of Neurology, Faculty of Health Science, Medical University of Warsaw, Warsaw, Poland. 11. Department of Neurology, Medical University of Warsaw, Warsaw, Poland. 12. Uzhhorod Regional Clinical Centre of Neurosurgery and Neurology, Uzhhorod, Ukraine. 13. Department of Neurology, Jagiellonian University Medical College, Krakow, Poland. 14. Department of Neurology, Medical University of Silesia, Katowice, Poland. 15. Uzhhorod National University, Uzhhorod, Ukraine. 16. Applied Neuroscience Research Group, Central European Institute of Technology, Masaryk University, Brno, Czech Republic. 17. Silesian Centre of Neurology, Katowice, Poland. 18. Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski Kraków University, Kraków, Poland. 19. Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. Electronic address: Wszolek.Zbigniew@mayo.edu.
Abstract
INTRODUCTION: Approximately 10% of patients with Parkinson disease (PD) present with early-onset disease (EOPD), defined as diagnosis before 50 years of age. Genetic factors are known to contribute to EOPD, with most commonly observed mutations in PRKN, PINK1, and DJ1 genes. The aim of our study was to analyze the frequency of PRKN, PINK1, and DJ1 mutations in an EOPD series from 4 neighboring European countries: Czech Republic, Germany, Poland, and Ukraine. METHODS: Diagnosis of PD was made based on UK Brain Bank diagnostic criteria in departments experienced in movement disorders (1 from Czech Republic, 1 from Germany, 9 from Poland, and 3 from Ukraine). EOPD was defined as onset at or before 50 years of age. Of the 541 patients recruited to the study, 11 were Czech, 38 German, 476 Polish, and 16 Ukrainian. All cohorts were fully screened with Sanger sequencing for PRKN, PINK1, and DJ1 and multiplex ligation-dependent probe amplification for exon dosage. RESULTS: PRKN homozygous or double heterozygous mutations were identified in 17 patients: 1 Czech (9.1%), 1 German (2.6%), 14 Polish (2.9%), and 1 Ukrainian (6.3%). PINK1 homozygous mutations were only identified in 3 Polish patients (0.6%). There were no homozygous or compound heterozygous DJ1 mutations in analyzed subpopulations. One novel variant in PRKN was identified in the Ukrainian series. CONCLUSION: In the analyzed cohorts, mutations in the genes PRKN, PINK1, and DJ1 are not frequently observed.
INTRODUCTION: Approximately 10% of patients with Parkinson disease (PD) present with early-onset disease (EOPD), defined as diagnosis before 50 years of age. Genetic factors are known to contribute to EOPD, with most commonly observed mutations in PRKN, PINK1, and DJ1 genes. The aim of our study was to analyze the frequency of PRKN, PINK1, and DJ1 mutations in an EOPD series from 4 neighboring European countries: Czech Republic, Germany, Poland, and Ukraine. METHODS: Diagnosis of PD was made based on UK Brain Bank diagnostic criteria in departments experienced in movement disorders (1 from Czech Republic, 1 from Germany, 9 from Poland, and 3 from Ukraine). EOPD was defined as onset at or before 50 years of age. Of the 541 patients recruited to the study, 11 were Czech, 38 German, 476 Polish, and 16 Ukrainian. All cohorts were fully screened with Sanger sequencing for PRKN, PINK1, and DJ1 and multiplex ligation-dependent probe amplification for exon dosage. RESULTS: PRKN homozygous or double heterozygous mutations were identified in 17 patients: 1 Czech (9.1%), 1 German (2.6%), 14 Polish (2.9%), and 1 Ukrainian (6.3%). PINK1 homozygous mutations were only identified in 3 Polish patients (0.6%). There were no homozygous or compound heterozygous DJ1 mutations in analyzed subpopulations. One novel variant in PRKN was identified in the Ukrainian series. CONCLUSION: In the analyzed cohorts, mutations in the genes PRKN, PINK1, and DJ1 are not frequently observed.
Authors: Massimo S Fiandaca; Russell R Lonser; J Bradley Elder; Mirosław Ząbek; Krystof S Bankiewicz Journal: Neurol Neurochir Pol Date: 2020-06-18 Impact factor: 1.621
Authors: Denise M Kay; Dawn Moran; Lina Moses; Parvoneh Poorkaj; Cyrus P Zabetian; John Nutt; Stewart A Factor; Chang-En Yu; Jennifer S Montimurro; Robert G Keefe; Gerard D Schellenberg; Haydeh Payami Journal: Ann Neurol Date: 2007-01 Impact factor: 10.422
Authors: Lynne Krohn; Francis P Grenn; Mary B Makarious; Jonggeol Jeffrey Kim; Sara Bandres-Ciga; Dorien A Roosen; Ziv Gan-Or; Mike A Nalls; Andrew B Singleton; Cornelis Blauwendraat Journal: Neurobiol Aging Date: 2020-03-10 Impact factor: 4.673
Authors: F Binkofski; K Reetz; C Gaser; R Hilker; J Hagenah; K Hedrich; T van Eimeren; A Thiel; C Büchel; P P Pramstaller; H R Siebner; C Klein Journal: Neurology Date: 2007-08-28 Impact factor: 9.910
Authors: Meike Kasten; Corinna Hartmann; Jennie Hampf; Susen Schaake; Ana Westenberger; Eva-Juliane Vollstedt; Alexander Balck; Aloysius Domingo; Franca Vulinovic; Marija Dulovic; Ingo Zorn; Harutyun Madoev; Hanna Zehnle; Christina M Lembeck; Leopold Schawe; Jennifer Reginold; Jana Huang; Inke R König; Lars Bertram; Connie Marras; Katja Lohmann; Christina M Lill; Christine Klein Journal: Mov Disord Date: 2018-04-11 Impact factor: 10.338